Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regenerative medicine regulatory policies: A systematic review and international comparison
Tingting Qiu, Eve Hanna, Monique Dabbous, et al.
Health Policy (2020) Vol. 124, Iss. 7, pp. 701-713
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Biomaterials to enhance stem cell transplantation
Bhushan N. Kharbikar, Priya Mohindra, Tejal A. Desai
Cell stem cell (2022) Vol. 29, Iss. 5, pp. 692-721
Open Access | Times Cited: 91
Optimizing mesenchymal stem cell extracellular vesicles for chronic wound healing: Bioengineering, standardization, and safety
Yusuke Shimizu, Edward Hosea Ntege, Yoshikazu Inoue, et al.
Regenerative Therapy (2024) Vol. 26, pp. 260-274
Open Access | Times Cited: 10
Brief summary of the regulatory frameworks of regenerative medicine therapies
Jung‐Hoon Yoon, Sukhyang Lee, Min Jung Kim, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 1
Collagen-Based Materials Modified by Phenolic Acids—A Review
Beata Kaczmarek, Olha Mazur
Materials (2020) Vol. 13, Iss. 16, pp. 3641-3641
Open Access | Times Cited: 46
Acceleration of Translational Mesenchymal Stromal Cell Therapy Through Consistent Quality GMP Manufacturing
Premkumar Jayaraman, Ryan G. Lim, Jacqueline Ng, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 35
Commercialization of regenerative-medicine therapies
Takumi Takahashi, Ryan P. Donahue, Rachel C. Nordberg, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 12, pp. 906-929
Closed Access | Times Cited: 15
Convergence of CRISPR and artificial intelligence: A paradigm shift in biotechnology
Mahintaj Dara, Mehdi Dianatpour, Negar Azarpira, et al.
Human Gene (2024) Vol. 41, pp. 201297-201297
Closed Access | Times Cited: 5
Intraoperative Creation of Tissue-Engineered Grafts with Minimally Manipulated Cells: New Concept of Bone Tissue Engineering In Situ
Olga Krasilnikova, Denis Baranovskii, A. O. Yakimova, et al.
Bioengineering (2022) Vol. 9, Iss. 11, pp. 704-704
Open Access | Times Cited: 21
Advances in Drug Delivery Integrated with Regenerative Medicine: Innovations, Challenges, and Future Frontiers
Manoochehr Rasekh, Muhammad Sohail Arshad, Zeeshan Ahmad
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 456-456
Open Access
Global harmonization in advanced therapeutics: balancing innovation, safety, and access
Ankit Dahiya, Kartikey Singh, Abdul Ashish, et al.
Personalized Medicine (2025), pp. 1-11
Closed Access
Advanced Therapies and Regulatory Framework in Different Areas of the Globe: Past, Present, and Future
Cleila Pimenta, Vitória Bettiol, Thuany Alencar‐Silva, et al.
Clinical Therapeutics (2021) Vol. 43, Iss. 5, pp. e103-e138
Closed Access | Times Cited: 19
Inclusivity and diversity: Integrating international perspectives on stem cell challenges and potential
Robin Fears, Hidenori Akutsu, Lara Theresa Alentajan-Aleta, et al.
Stem Cell Reports (2021) Vol. 16, Iss. 8, pp. 1847-1852
Open Access | Times Cited: 18
U-Net Convolutional Neural Network for Real-Time Prediction of the Number of Cultured Corneal Endothelial Cells for Cellular Therapy
Naoki Okumura, Takeru Nishikawa, C. Imafuku, et al.
Bioengineering (2024) Vol. 11, Iss. 1, pp. 71-71
Open Access | Times Cited: 2
Biomineral-Based Composite Materials in Regenerative Medicine
Sung Ho Kim, Mi‐Ran Ki, Youngji Han, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6147-6147
Open Access | Times Cited: 2
The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects
Tingting Qiu, Yitong Wang, Shuyao Liang, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 10, pp. 2269-2281
Open Access | Times Cited: 16
Impact and challenges of enactment for advanced regenerative medicine in South Korea
Dong‐Sook Kim, SeungJin Bae
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 10
Amortization of gene replacement therapies: A health policy analysis exploring a mechanism for mitigating budget impact of high-cost treatments
Monique Dabbous, Mondher Toumi, Steven Simoens, et al.
Health Policy (2021) Vol. 126, Iss. 1, pp. 49-59
Open Access | Times Cited: 10
Challenges in the market access of regenerative medicines, and implications for manufacturers and decision-makers: a systematic review
Tingting Qiu, Michał Pochopień, Eve Hanna, et al.
Regenerative Medicine (2022) Vol. 17, Iss. 3, pp. 119-139
Closed Access | Times Cited: 7
Regulatory Aspects of Regenerative Medicine in the United States and Abroad
Dana Jaalouk, Anesh Prasai, David Goldberg, et al.
Dermatological Reviews (2024) Vol. 5, Iss. 4
Closed Access | Times Cited: 1
An evidence map of randomised controlled trials evaluating genetic therapies
Eric Apaydin, Andrea S. Richardson, Sangita M. Baxi, et al.
BMJ evidence-based medicine (2020) Vol. 26, Iss. 4, pp. 194-194
Closed Access | Times Cited: 7
Regenerative Medicine in South Korea: Bridging the Gap Between Authorization and Reimbursement
Dong‐Sook Kim, Geunwoo Lee, Hyungyung Cho, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 7
Considering potential solutions for limitations and challenges in the health economic evaluation of gene therapies
Michał Pochopień, Tingting Qiu, Samuel Aballéa, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2021) Vol. 21, Iss. 6, pp. 1145-1158
Closed Access | Times Cited: 6
An Overview of the Supramolecular Systems for Gene and Drug Delivery in Tissue Regeneration
Saketh Reddy Ranamalla, Alina Porfire, Ioan Tomuță, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1733-1733
Open Access | Times Cited: 4
Medico-Legal Implications and Regulatory Frameworks of Regenerative Orthopaedics
Madhan Jeyaraman, Prince M Paul, Naveen Jeyaraman, et al.
Cureus (2023)
Open Access | Times Cited: 2
Reinforcing Collaboration and Harmonization to Unlock the Potentials of Advanced Therapy Medical Products: Future Efforts Are Awaited From Manufacturers and Decision-Makers
Tingting Qiu, Shuyao Liang, Yitong Wang, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top